These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23887185)

  • 1. Initial clinical validation of an embedded performance validity measure within the automated neuropsychological metrics (ANAM).
    Roebuck-Spencer TM; Vincent AS; Gilliland K; Johnson DR; Cooper DB
    Arch Clin Neuropsychol; 2013 Nov; 28(7):700-10. PubMed ID: 23887185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the ANAM General Neuropsychological Screening Battery (ANAM GNS) for detecting neurocognitive impairment in a mixed clinical sample.
    Woodhouse J; Heyanka DJ; Scott J; Vincent A; Roebuck-Spencer T; Domboski-Davidson K; O'Mahar K; Adams R
    Clin Neuropsychol; 2013; 27(3):376-85. PubMed ID: 23368639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of ANAM for cognitive screening in a mixed clinical sample.
    Vincent AS; Roebuck-Spencer TM; Cox-Fuenzalida LE; Block C; Scott JG; Kane R
    Appl Neuropsychol Adult; 2018; 25(4):366-375. PubMed ID: 28448160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial validation of the Pediatric Automated Neuropsychological Assessment Metrics for childhood-onset systemic lupus erythematosus.
    Brunner HI; Ruth NM; German A; Nelson S; Passo MH; Roebuck-Spencer T; Ying J; Ris D
    Arthritis Rheum; 2007 Oct; 57(7):1174-82. PubMed ID: 17907235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus.
    Roebuck-Spencer TM; Yarboro C; Nowak M; Takada K; Jacobs G; Lapteva L; Weickert T; Volpe B; Diamond B; Illei G; Bleiberg J
    Arthritis Rheum; 2006 Jun; 55(3):434-41. PubMed ID: 16739211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing change with the Automated Neuropsychological Assessment Metrics (ANAM): issues and challenges.
    Roebuck-Spencer T; Sun W; Cernich AN; Farmer K; Bleiberg J
    Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S79-87. PubMed ID: 17118623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated neuropsychological assessment metrics (ANAM) measures of cognitive effects of Alzheimer's disease.
    Levinson D; Reeves D; Watson J; Harrison M
    Arch Clin Neuropsychol; 2005 May; 20(3):403-8. PubMed ID: 15797175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Repeatable Battery for the Assessment of Neuropsychological Status effort scale.
    Novitski J; Steele S; Karantzoulis S; Randolph C
    Arch Clin Neuropsychol; 2012 Mar; 27(2):190-5. PubMed ID: 22277124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity Evidence for the Use of Automated Neuropsychologic Assessment Metrics As a Screening Tool for Cognitive Impairment in Systemic Lupus Erythematosus.
    Tayer-Shifman OE; Green R; Beaton DE; Ruttan L; Wither JE; Tartaglia MC; Kakvan M; Lombardi S; Anderson N; Su J; Bonilla D; Zandy M; Choi MY; Fritzler MJ; Touma Z
    Arthritis Care Res (Hoboken); 2020 Dec; 72(12):1809-1819. PubMed ID: 31628718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test-retest reliability and practice effects for the ANAM General Neuropsychological Screening battery.
    Vincent AS; Roebuck-Spencer TM; Fuenzalida E; Gilliland K
    Clin Neuropsychol; 2018 Apr; 32(3):479-494. PubMed ID: 28832273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and specificity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease.
    Kaszás B; Kovács N; Balás I; Kállai J; Aschermann Z; Kerekes Z; Komoly S; Nagy F; Janszky J; Lucza T; Karádi K
    Parkinsonism Relat Disord; 2012 Jun; 18(5):553-6. PubMed ID: 22405839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the Automated Neuropsychological Assessment Metrics (ANAM) in detecting cognitive impairment in heart failure patients.
    Xie SS; Goldstein CM; Gathright EC; Gunstad J; Dolansky MA; Redle J; Hughes JW
    Heart Lung; 2015; 44(5):387-94. PubMed ID: 26354858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Validity Measure for the Automated Neuropsychological Assessment Metrics.
    Meyers JE; Miller RM; Vincent AS
    Arch Clin Neuropsychol; 2022 Nov; 37(8):1765-1771. PubMed ID: 35780310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construct validity of selected Automated Neuropsychological Assessment Metrics (ANAM) battery measures.
    Kabat MH; Kane RL; Jefferson AL; DiPino RK
    Clin Neuropsychol; 2001 Dec; 15(4):498-507. PubMed ID: 11935451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying and monitoring cognitive deficits in clinical populations using Automated Neuropsychological Assessment Metrics (ANAM) tests.
    Kane RL; Roebuck-Spencer T; Short P; Kabat M; Wilken J
    Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S115-26. PubMed ID: 17101258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computerized measurement of cognitive impairment and associated neuropsychiatric dimensions.
    Gottschalk LA; Bechtel RJ; Maguire GA; Harrington DE; Levinson DM; Franklin DL; Carcamo D
    Compr Psychiatry; 2000; 41(5):326-33. PubMed ID: 11011827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated neuropsychological assessment metrics (ANAM) and Woodcock-Johnson III Tests of Cognitive Ability: a concurrent validity study.
    Jones WP; Loe SA; Krach SK; Rager RY; Jones HM
    Clin Neuropsychol; 2008 Mar; 22(2):305-20. PubMed ID: 17853133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor analysis of computerized and traditional tests used in mild brain injury research.
    Bleiberg J; Kane RL; Reeves DL; Garmoe WS; Halpern E
    Clin Neuropsychol; 2000 Aug; 14(3):287-94. PubMed ID: 11262703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validating a Pragmatic Approach to Cognitive Screening in Stroke Prevention Clinics Using the Montreal Cognitive Assessment.
    Swartz RH; Cayley ML; Lanctôt KL; Murray BJ; Smith EE; Sahlas DJ; Herrmann N; Cohen A; Thorpe KE
    Stroke; 2016 Mar; 47(3):807-13. PubMed ID: 26903584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of four embedded validity indices for the RBANS in a memory disorders clinic.
    Paulson D; Horner MD; Bachman D
    Arch Clin Neuropsychol; 2015 May; 30(3):207-16. PubMed ID: 25783523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.